GSK Handling Of Paxil Data On Pediatric Use Is Subject Of N.Y. Lawsuit
This article was originally published in The Pink Sheet Daily
Executive Summary
The state attorney general alleges that GSK failed to publish information about the safety and efficacy of Paxil in children. The lawsuit seeks disgorgement of profits. GSK maintains that it has publicly communicated the data from its pediatric studies.